Skip to content

Effect of Inspiratory Muscle Training on Duration of Mechanical Ventilation Support

Inspiratory Muscle Strength Training in Ventilator Dependent Patients

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01108575
Enrollment
76
Registered
2010-04-22
Start date
2010-05-31
Completion date
2013-01-31
Last updated
2013-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Failure

Keywords

Mechanical ventilation, mechanical ventilation weaning, inspiratory muscle strength training, Patients admitted to a surgical intensive care unit who are expected to receive mechanical ventilation for more than three days.

Brief summary

A growing body of knowledge has documented that the diaphragm, the primary muscle of breathing, atrophies and weakens within days of instituting mechanical ventilation support. Diaphragm weakness has been implicated as a major contributor to difficulty with weaning, or breathing without ventilator support. This study will test whether instituting a diaphragm strength training rehabilitation program will reduce the time patients require mechanical ventilation in a surgical intensive care setting.

Interventions

OTHERIMST

inspiratory muscle strength training

OTHERSham IMST

sham inspiratory muscle strength training

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1\. Admission to general surgical intensive care unit with respiratory failure and expected to require mechanical ventilation support for more than 72 hours.

Exclusion criteria

1. inability to follow simple, one step commands such as inspire forcefully, 2. patients with prior arrangements to be transferred to other facilities when stabilized, 3. any contraindications to disconnecting pt from ventilator for SHAM or IMST treatment, 4. unstable or difficult airway upon ICU admission and predicted to last for more than 72 hours, 5. use of more than minimal vasopressor or vasodilatatory agents as a continuous infusion, 6. severe dysrhythmias, 7. acute coronary syndrome 8. pulmonary contraindications (pneumon/hemothorax, flail chest), 9. acute surgical problems arising in the immediate post operative period (serious postoperative bleeding, wound dehiscence, etc). When and if these problems resolve and the patient meets other entry criteria, they will be eligible to be recruited for participation. 10. active neuromuscular diseases that would prevent or interfere with responding to strength training (e.g., amyotrophic lateral sclerosis, multiple sclerosis, myasthenia gravis, polymyositis, muscular dystrophy or other dystrophies and myopathies) 11. spinal cord injuries.

Design outcomes

Primary

MeasureTime frame
Duration of mechanical ventilation supportPatients will be observed for up to 28 days following admission to the ICU

Secondary

MeasureTime frame
Maximal inspiratory pressurePatients will be observed for up to 28 days following admission to the ICU

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026